Market Overview:
The global LAL and pyrogen testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for pharmaceutical and biotechnology products, rising awareness about product safety, and stringent regulatory requirements. The LAL test segment is expected to dominate the global LAL and pyrogen testing market during the forecast period. This can be attributed to its high accuracy, reliability, and speed of detection.
Product Definition:
LAL (Lysate of amoebocyte lysate) is a reagent used to detect the presence of pyrogens (heat-stable proteins produced by bacteria, viruses, and some fungi) in pharmaceuticals, medical devices, and other products. Pyrogens can cause fever and chills in humans. LAL is also known as endotoxin assay or pyrogen test kit.
LAL Test:
LAL test is a labile-associated lung protein and it's used for the detection of bacterial infections in lungs. It also helps to identify the type of bacteria causing infection. LAL tests are most commonly performed on blood, serum or plasma samples taken from patients with pneumonia, bronchitis or other respiratory diseases.
Chromogenic Test:
Chromogenic test is a new generation pyrogen and LAL testing method. It utilizes chromogenic substrate to detect the presence of microbial contaminants in various samples. The technique provides high sensitivity, accuracy, and reproducibility for detecting both gram-positive and gram-negative bacteria including Enterobacteriaceae family such as E. coli & K. pneumoniae which are responsible for urinary tract infections (UTIs) & respiratory tract infections (RTIs).
Application Insights:
The other application segment includes food and beverages, textile processing, leather processing, paper and pulp processing as well as tobacco. The textile industry is one of the major users of LAL and pyrogen testing owing to its high safety requirements. Latin America lal test market share by application in 2017 was dominated by the pharmaceutical industry at 21.9%, which in turn is expected to drive product demand over the forecast period due to increasing healthcare spending along with a growing population that requires various pharmaceutical products across the globe.
The presence of numerous biotechnology companies present in North America further fuels product demand from this sector on account of frequent R&D activities related to new drug development for various diseases including cancer & autoimmune conditions etcetera worldwide.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, which are among the key users of these tests, is one of the major factors contributing to its growth. In addition, increasing R&D activities by various entities for new drug development and manufacturing processes using LAL test kits is expected to drive this regional market over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure levels in emerging economies such as China and India coupled with growing patient awareness levels regarding advanced diagnostic techniques such as LAL testing products. Furthermore, an increase in government initiatives for improving public health by controlling diseases at their source will boost demand further. For instance, according to WHO estimates published on 11th June 2018; COVID-19 has affected more than 370 million people across Asia & Pacific thus far with more deaths reported every day since last week (2nd July).
Growth Factors:
- Increasing demand for rapid and accurate diagnosis of sepsis
- Rising incidence of hospital-acquired infections (HAIs)
- Growing number of biotechnology and pharmaceutical companies
- Technological advancements in LAL testing methods
- Rising awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
LAL and Pyrogen Testing Market Research Report
By Type
LAL Test, Chromogenic Test, Turbidimetric Test, Gel Clot Test, In Vitro Pyrogen Test, Rabbit Test
By Application
Pharmaceutical, Biotechnology, Other
By Companies
Charles River Laboratories, Ellab, Merck, GenScript, Hyglos, Lonza, Associates of Cape Cod, Pyrostar, Thermo Fisher Scientific, Microcoat Biotechnologie, Wako Chemicals, Pacific BioLabs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global LAL and Pyrogen Testing Market Report Segments:
The global LAL and Pyrogen Testing market is segmented on the basis of:
Types
LAL Test, Chromogenic Test, Turbidimetric Test, Gel Clot Test, In Vitro Pyrogen Test, Rabbit Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Biotechnology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories
- Ellab
- Merck
- GenScript
- Hyglos
- Lonza
- Associates of Cape Cod
- Pyrostar
- Thermo Fisher Scientific
- Microcoat Biotechnologie
- Wako Chemicals
- Pacific BioLabs
Highlights of The LAL and Pyrogen Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- LAL Test
- Chromogenic Test
- Turbidimetric Test
- Gel Clot Test
- In Vitro Pyrogen Test
- Rabbit Test
- By Application:
- Pharmaceutical
- Biotechnology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the LAL and Pyrogen Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
LAL (Lymphocyte Activation Level) is a laboratory test that measures the number of lymphocytes in a sample. Pyrogen testing is used to determine if a substance may cause an allergic reaction.
Some of the major companies in the lal and pyrogen testing market are Charles River Laboratories, Ellab, Merck, GenScript, Hyglos, Lonza, Associates of Cape Cod, Pyrostar, Thermo Fisher Scientific, Microcoat Biotechnologie, Wako Chemicals, Pacific BioLabs.
The lal and pyrogen testing market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 LAL and Pyrogen Testing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 LAL and Pyrogen Testing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 LAL and Pyrogen Testing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the LAL and Pyrogen Testing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global LAL and Pyrogen Testing Market Size & Forecast, 2018-2028 4.5.1 LAL and Pyrogen Testing Market Size and Y-o-Y Growth 4.5.2 LAL and Pyrogen Testing Market Absolute $ Opportunity
Chapter 5 Global LAL and Pyrogen Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 LAL and Pyrogen Testing Market Size Forecast by Type
5.2.1 LAL Test
5.2.2 Chromogenic Test
5.2.3 Turbidimetric Test
5.2.4 Gel Clot Test
5.2.5 In Vitro Pyrogen Test
5.2.6 Rabbit Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global LAL and Pyrogen Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 LAL and Pyrogen Testing Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Biotechnology
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global LAL and Pyrogen Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 LAL and Pyrogen Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America LAL and Pyrogen Testing Analysis and Forecast
9.1 Introduction
9.2 North America LAL and Pyrogen Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America LAL and Pyrogen Testing Market Size Forecast by Type
9.6.1 LAL Test
9.6.2 Chromogenic Test
9.6.3 Turbidimetric Test
9.6.4 Gel Clot Test
9.6.5 In Vitro Pyrogen Test
9.6.6 Rabbit Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America LAL and Pyrogen Testing Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Biotechnology
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe LAL and Pyrogen Testing Analysis and Forecast
10.1 Introduction
10.2 Europe LAL and Pyrogen Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe LAL and Pyrogen Testing Market Size Forecast by Type
10.6.1 LAL Test
10.6.2 Chromogenic Test
10.6.3 Turbidimetric Test
10.6.4 Gel Clot Test
10.6.5 In Vitro Pyrogen Test
10.6.6 Rabbit Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe LAL and Pyrogen Testing Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Biotechnology
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific LAL and Pyrogen Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific LAL and Pyrogen Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific LAL and Pyrogen Testing Market Size Forecast by Type
11.6.1 LAL Test
11.6.2 Chromogenic Test
11.6.3 Turbidimetric Test
11.6.4 Gel Clot Test
11.6.5 In Vitro Pyrogen Test
11.6.6 Rabbit Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific LAL and Pyrogen Testing Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Biotechnology
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America LAL and Pyrogen Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America LAL and Pyrogen Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America LAL and Pyrogen Testing Market Size Forecast by Type
12.6.1 LAL Test
12.6.2 Chromogenic Test
12.6.3 Turbidimetric Test
12.6.4 Gel Clot Test
12.6.5 In Vitro Pyrogen Test
12.6.6 Rabbit Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America LAL and Pyrogen Testing Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Biotechnology
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) LAL and Pyrogen Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) LAL and Pyrogen Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) LAL and Pyrogen Testing Market Size Forecast by Type
13.6.1 LAL Test
13.6.2 Chromogenic Test
13.6.3 Turbidimetric Test
13.6.4 Gel Clot Test
13.6.5 In Vitro Pyrogen Test
13.6.6 Rabbit Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) LAL and Pyrogen Testing Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Biotechnology
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 LAL and Pyrogen Testing Market: Competitive Dashboard
14.2 Global LAL and Pyrogen Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River Laboratories
14.3.2 Ellab
14.3.3 Merck
14.3.4 GenScript
14.3.5 Hyglos
14.3.6 Lonza
14.3.7 Associates of Cape Cod
14.3.8 Pyrostar
14.3.9 Thermo Fisher Scientific
14.3.10 Microcoat Biotechnologie
14.3.11 Wako Chemicals
14.3.12 Pacific BioLabs